BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers KN Maxwell, B Wubbenhorst, BM Wenz, D De Sloover, J Pluta, L Emery, ... Nature communications 8 (1), 319, 2017 | 277 | 2017 |
Antibody evasion of SARS-CoV-2 Omicron BA. 1, BA. 1.1, BA. 2, and BA. 3 sub-lineages J Ai, X Wang, X He, X Zhao, Y Zhang, Y Jiang, M Li, Y Cui, Y Chen, ... Cell host & microbe 30 (8), 1077-1083. e4, 2022 | 148 | 2022 |
Quiescin sulfhydryl oxidase 1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by driving EGFR endosomal trafficking and inhibiting NRF2 activation J Sun, C Zhou, Y Zhao, X Zhang, W Chen, Q Zhou, B Hu, D Gao, L Raatz, ... Redox biology 41, 101942, 2021 | 104 | 2021 |
Genetic and genomic characterization of 462 melanoma patient-derived xenografts, tumor biopsies, and cell lines B Garman, IN Anastopoulos, C Krepler, P Brafford, K Sproesser, Y Jiang, ... Cell reports 21 (7), 1936-1952, 2017 | 78 | 2017 |
Antibody resistance of SARS-CoV-2 Omicron BA. 1, BA. 1.1, BA. 2 and BA. 3 sub-lineages J Ai, X Wang, X He, X Zhao, Y Zhang, Y Jiang, M Li, Y Cui, Y Chen, ... bioRxiv, 2022.04. 07.487489, 2022 | 14 | 2022 |
Association of genetic polymorphisms of de novo nucleotide biosynthesis with increased CHD susceptibility in the northern Chinese population YC Jiang, LL Kuang, SN Sun, WY Duan, B Qiao, HY Wang Clinical genetics 91 (5), 748-755, 2016 | 8 | 2016 |
Rare variants in TULP3 abolish the suppressive effect on sonic hedgehog signaling and contribute to human neural tube defects L Kuang, Y Jiang, S Chen, K Su, R Peng, X Yang, H Wang Genes & Diseases 9 (5), 1174, 2022 | 6 | 2022 |
De Novo Origin of VCY2 from Autosome to Y-Transposed Amplicon PR Cao, L Wang, YC Jiang, YS Yi, F Qu, TC Liu, Y Lv PLoS One 10 (3), e0119651, 2015 | 5 | 2015 |
ANTI-HUMAN PD-1 ANTIBODY AND USE THEREOF YC Jiang WO Patent WO2,021,244,134, 2021 | | 2021 |
Bifunctional antibody for relieving immunosuppression in tumor immune microenvironment, and application and preparation method thereof YC Jiang CN Patent App. CN113,501,879 A, 2021 | | 2021 |
Double-target chimeric antigen receptor for simultaneously targeting CD19 and BCMA and application thereof YC Jiang CN Patent App. CN112,592,927 A, 2021 | | 2021 |
SHMT1 基因启动子的 rs638416 位点与先天性心脏病的相关性. 姜钰超, 匡乐乐, 王红艳, 段文元, 蔡春泉 Fudan University Journal of Medical Sciences 43 (4), 2016 | | 2016 |
Association of rs638416 in SHMT1 promoter and congenital heart diseases YC Jiang 2016年43卷04期 429-434页 43 (04), 429-434, 2016 | | 2016 |
Building method and use of antineoplastic compound screening model YC Jiang CN Patent CN104,593,423 A, 2015 | | 2015 |